Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 18.5.1. Insulins | No observations |
| PAHO Strategic Fund Medicine List | 8.2. Insulins and other antidiabetic agents |
Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |
| Peru | 18.5 Insulins and Other Anti-Diabetics | No observations |
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 39. Hipoglucemiantes e hiperglucemiantes | No observations |
| Belize. National Drug Formulary | 18.07 Insulins and other antidiabetic agents | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 18.5.1. Insulins | No observations |
| PAHO Strategic Fund Medicine List | 8.2. Insulins and other antidiabetic agents |
Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |
| Haiti. National List of Essential Medicines | 18.04 Antidiabetics and other drugs used in diabetes | No observations |
| List | Section | Observation |
|---|---|---|
| PAHO Strategic Fund Medicine List | 8.2. Insulins and other antidiabetic agents |
Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |
| List | Section | Observation |
|---|---|---|
| Barbados. Barbados National Drug Formulary (BNDF) | 68.20.08 Insulins | No observations |